Neurocrine Biosciences (NBIX) Debt Ratio (2018 - 2024)

Neurocrine Biosciences' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.04 for Q1 2024.

• Quarterly Debt Ratio changed N/A year-over-year to 0.04 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.04 (changed N/A YoY) and the FY2023 annual result came in at 0.05, down 26.85% from the prior year.
• Debt Ratio was 0.04 for Q1 2024 at Neurocrine Biosciences, down from 0.05 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.28 in Q3 2020 and bottomed at 0.04 in Q1 2024.
• A 4-year average of 0.12 and a median of 0.07 in 2022 frame the typical range for Debt Ratio.
• Peak annual rise in Debt Ratio reached 24.43% in 2023, while the deepest fall reached 26.85% in 2023.
• Neurocrine Biosciences' Debt Ratio stood at 0.28 in 2020, then tumbled by 74.72% to 0.07 in 2022, then dropped by 26.85% to 0.05 in 2023, then tumbled by 32.4% to 0.04 in 2024.
• Business Quant data shows NBIX's Debt Ratio at 0.04 in Q1 2024, 0.05 in Q4 2023, and 0.06 in Q3 2023.